A

Adial Pharmaceuticals
D

ADIL

2.30000
USD
-0.12
(-4.96%)
مغلق
حجم التداول
19,233
الربح لكل سهم
-7
العائد الربحي
-
P/E
-0
حجم السوق
2,489,021
المقالات

العنوان: Adial Pharmaceuticals Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.